SADH:XETRA:XETRA-Amundi MSCI USA ESG Leaders UCITS ETF Acc EUR Hedged (EUR)

ETF | Others |

Last Closing

USD 79.46

Change

+0.78 (+0.99)%

Market Cap

USD 0.22B

Volume

3.68K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-1.21 (-2.55%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

-3.43 (-3.24%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.64 (-2.61%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.33 (-2.38%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.16 (-2.95%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.78 (-3.22%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.48 (-3.48%)

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.19 (+0.36%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.32 (-3.10%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.21 (-0.17%)

USD 12.26B

ETFs Containing SADH:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.24% 23% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.24% 23% F 25% F
Trailing 12 Months  
Capital Gain 10.10% 51% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.10% 51% F 52% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 10.57% 65% D 65% D
Dividend Return 10.57% 64% D 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.37% 51% F 60% D-
Risk Adjusted Return 85.43% 73% C 76% C+
Market Capitalization 0.22B 55% F 41% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike